Friday 6 November 2026 Export INSM’s income statement to Excel — free account

Insmed, Inc.

INSM Healthcare Biotechnology

Insmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $606.4 million, up 66.7% from fiscal 2024.

Revenue: +268.4%
EPS: +73.8%
Free cash flow: +81.1%
Total debt: +0.27%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

112.32 3.56 +3.27%

Follow INSM

Alert me

Market cap: $23.9B
P/E: 0.0×
Fwd P/E: −64.6×
Dividend yield: —
F-score: 4/9
Altman Z: 9.29
Beneish M: −1.90
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Insmed, Inc. (INSM) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Insmed, Inc. (INSM) trades at a P/B ratio of 32.6×. Over the past ten years it has ranged from 0.0× (June 2024) to 315× (August 2024); the current reading is higher than 85% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/INSM/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Insmed, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/INSM/metrics/pb-ratio">Insmed, Inc. (INSM) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	46.9×	18.10%
FY2024	39.7×	—
FY2023	0.0×	—
FY2022	26.8×	260.63%
FY2021	7.4×	(36.83%)
FY2020	11.8×	52.62%
FY2019	7.7×	59.32%
FY2018	4.8×	—

Period	P/B ratio	Change
Sep 2026	34.4×	12.40%
Jun 2026	30.6×	(38.80%)
Mar 2026	50.0×	6.65%
Dec 2025	46.9×	45.33%
27 more quarters	Free account

Against its own ten years

Low 0.0× High 315×

Ten-year median 6.5×

Current reading's percentile 81

Company	P/B ratio
BBIO BridgeBio Pharma, Inc. compare	n/m
BNTX BioNTech SE Sponsored ADR compare	1.1×
INCY Incyte Corporation compare	4.3×
ROIV Roivant Sciences Ltd. compare	5.4×
GMAB Genmab A/S Sponsored ADR compare	5.5×
ALNY Alnylam Pharmaceuticals, Inc. compare	5.8×
EXEL Exelixis, Inc. compare	9.3×
ASND Ascendis Pharma A/S compare	9.8×
INSM Insmed, Inc.	32.6×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Insmed, Inc. (INSM) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on INSM

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on INSM

Stockrow Weekly